EPO Patents = 1

Forward Citations = 22

Loading Chart...

8 inventors (with patents filed for the assignee):

Daniel R Getts (5 out of 19 patents)

Ryan Pearson (2 out of 3 patents)

Lonnie D Shea (1 out of 20 patents)

4. John Puisis (1 out of 2 patents)

5. Rachael Terry (1 out of 2 patents)

6. Nicholas King (1 out of 2 patents)

7. Frank Fokta (1 out of 1 patent)

8. James Herrmann (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11510996 - Covalent polymer-antigen conjugated particles (2022-11-29),

2. 11484506 - Process for the preparation of tolerizing immune-modulating particles (2022-11-01),

3. 10471093 - Modified immune-modulating particles (2019-11-12),

4. 9919005 - Immune-modifying nanoparticles for the treatment of inflammatory diseases (2018-03-20),

5. 9913883 - Immune-modifying nanoparticles for the treatment of inflammatory diseases (2018-03-13),

Cour Pharmaceuticals Development Company, Inc. is a biopharmaceutical company focused on developing novel therapies for autoimmune diseases. The company's innovative approach combines cutting-edge drug delivery technology with a deep understanding of the immune system to create targeted treatments with improved efficacy and safety profiles. With a pipeline of promising drug candidates and a commitment to improving the lives of patients, Cour Pharmaceuticals is poised to make a significant impact in the field of autoimmune disease treatment.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#34 in Northbrook, IL

#2,359 in Illinois

#50,174 in US

Northbrook, IL, United States of America

Cour Pharmaceuticals Development Company, Inc.